Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation

Study acronym: EPIC-AIR
StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Dec 31, 2026 → Mar 31, 2027
Primary endpoints added 1 → 3 primary endpoints
See other at-risk trials from University of Leicester

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 9 more changesShow less
    • Start date: May 2026 to Oct 2026
    • Primary completion pushed from Dec 31, 2026 to Mar 31, 2027
    • Study completion pushed from Mar 1, 2027 to Aug 1, 2027
    • Interventions modified
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description shortened, about 2,626 words
    • Publications: details revised at 3 of 3 entries
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
University of Leicester
48 trials monitored
See 1 trial at risk
Heart Disease
8,814 trials monitored
See 428 trials at risk
Heart Failure
2,000 trials monitored
See 115 trials at risk
Coronary Artery Disease
1,621 trials monitored
See 71 trials at risk
and 2 more diseases
The primary objective of EPIC-AIR is to evaluate the feasibility and potential effectiveness of integrating real-time air pollution monitoring into cardiac rehabilitation (CR) and pulmonary rehabilitation (PR) programmes via an online platform that delivers both exercise prescription and air pollution guidance. Specific objectives are: (1) to determine whether access to real-time air quality data reduces modelled ambient pollution exposure (PM2.5, PM10 and NO2) during outdoor physical activity in CR/PR patients and healthy volunteers; (2) to assess the feasibility of the trial design, including recruitment, randomisation, retention, adherence and completeness of outcome data; (3) to measure the impact of the intervention on physical activity levels, health-related quality of life and cardiovascular biomarkers; and (4) to inform the design and sample size of a future definitive randomised controlled trial
Trial Details
NCT Number NCT07500948
Lead Sponsor University of Leicester
Conditions
(from sponsor)		 Cardiovascular Disease, Asthma, COPD, Interstitial Lung Disease Due to Systemic Disease, Heart Failure, Coronary Heart Disease (CHD)
Related terms Asthma, Cardiovascular Diseases, Coronary Disease, Heart Failure, Motor Activity, Pulmonary Disease, Chronic Obstructive
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov